BALA CYNWYD, Pa., July 7, 2014 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Enventis
Corporation ("Enventis" or the "Company") (Nasdaq: ENVE) relating
to the proposed acquisition Consolidated Communications Holdings,
Inc. ("Consolidated Communications").
Click here to learn more about the investigation
http://brodsky-smith.com/784-enve-enventis-corporation.html, or
call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Enventis shareholders will
receive only 0.7402 shares of Consolidated Communications common
stock for each share of Enventis stock they own. The proposed
transaction is valued at approximately $350
million, including $123
million of Enventis' net debt. The investigation concerns
possible breaches of fiduciary duty and other violations of state
law by the Board of Directors of Enventis for not acting in the
Company's shareholders' best interests in connection with the sale
process.
If you own shares of Enventis common stock and wish to discuss
the legal ramifications of the investigation, or have any
questions, you may e-mail or call the law office of Brodsky &
Smith, LLC who will, without obligation or cost to you, attempt to
answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith,
LLC, Two Bala Plaza, Suite 602, Bala
Cynwyd, PA 19004, by e-mail at
investorrelations@brodsky-smith.com, by visiting
http://brodsky-smith.com/784-enve-enventis-corporation.html, or
calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and case action lawsuits. The attorneys at Brodsky &
Smith have been appointed by numerous courts throughout the country
to serve as lead counsel in class actions and successfully
recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar
outcome.
SOURCE Brodsky & Smith, LLC